News

While the mortality rate for breast cancer in the U.S. has significantly declined from its peak in 1989, incidence among younger women has steadily increased each year since 2001, according to the American Cancer Society.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.

According to the National Cancer Institute, about 40% of women have dense breast tissue, which makes it more difficult to find breast cancer early.

Dr. Mary Mitchell, chief of breast radiology at Saint Luke's, talks to KSHB about what dense breast tissue is and how it impacts your risk of developing breast cancer.

We are talking with Marji Stark, lactation consultant at Saint Luke’s East Hospital, about the breastfeeding journey for mothers who have prematurely given birth to their babies.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.